Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
Cell Cycle (Georgetown, Tex.)|April 8, 2010
SOX2 in squamous cell carcinoma: amplifying a pleiotropic oncogene along carcinogenesisThomas Hussenet, Stanislas du Manoir
Cell Cycle (Georgetown, Tex.)|December 22, 2009
An adult tissue-specific stem cell molecular phenotype is activated in epithelial cancer stem cells and correlated to patient outcomeThomas Hussenet, Doulaye Dembélé, Nadine Martinet, et al.
Cancer Genetics and Cytogenetics|August 30, 2006
Overlapping 3q28 amplifications in the COMA cell line and undifferentiated primary sarcomaThomas Hussenet, Nedjoua Mallem, Richard Redon, et al.
Cancer Research|November 5, 2002
Amplicon mapping and transcriptional analysis pinpoint cyclin L as a candidate oncogene in head and neck cancerRichard Redon, Thomas Hussenet, Gaétan Bour, et al.
BMC Cancer|December 8, 2009
Signalling with retinoids in the human lung: validation of new tools for the expression study of retinoid receptorsStéphane Poulain, Stéphanie Lacomme, Shyue-Fang Battaglia-Hsu, et al.
The Journal of Pathology|March 18, 2022
In high-grade ovarian carcinoma, platinum-sensitive tumor recurrence and acquired-resistance derive from quiescent residual cancer cells that overexpress CRYAB, CEACAM6, and SOX2Stanislas du Manoir, Hélène Delpech, Béatrice Orsetti, et al.
Diagnostic Molecular Pathology : the American Journal of Surgical Pathology, Part B|November 6, 2010
Mapping EGFR1 mutations in patients with lung adenocarcinomaFotis Vlastos, Julie Zinszner, Thomas Hussenet, et al.
Cancer Research|September 18, 2004
Genomic and expression profiling of chromosome 17 in breast cancer reveals complex patterns of alterations and novel candidate genesBéatrice Orsetti, Mélanie Nugoli, Nathalie Cervera, et al.
Plos One|February 4, 2010
SOX2 is an oncogene activated by recurrent 3q26.3 amplifications in human lung squamous cell carcinomasThomas Hussenet, Soraya Dali, Julien Exinger, et al.
Molecular Oncology|January 8, 2014
Breast tumor PDXs are genetically plastic and correspond to a subset of aggressive cancers prone to relapseStanislas du Manoir, Béatrice Orsetti, Rui Bras-Gonçalves, et al.
Pageof 3